{
    "Trade/Device Name(s)": [
        "B. anthracis Real-Time PCR Assay"
    ],
    "Submitter Information": "Centers for Disease Control and Prevention",
    "510(k) Number": "K140426",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051713",
        "K071188"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHT"
    ],
    "Summary Letter Date": "May 22, 2014",
    "Summary Letter Received Date": "February 25, 2014",
    "Submission Date": "February 14, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3045"
    ],
    "Regulation Name(s)": [
        "In vitro Diagnostic Devices for Bacillus spp. Detection"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Bacillus anthracis chromosomal DNA",
        "Bacillus anthracis plasmid DNA"
    ],
    "Specimen Type(s)": [
        "Respiratory samples",
        "Whole blood",
        "Serum",
        "Plasma",
        "Swabs from lesions",
        "Cerebrospinal fluid",
        "Pleural fluid",
        "Bacterial culture isolates"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems 7500 Fast Dx Real-Time PCR System",
        "Cepheid SmartCycler I",
        "Cepheid SmartCycler II"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "RT-PCR"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for CDC B. anthracis Real-Time PCR Assay for detection of B. anthracis chromosomal and plasmid DNA from various clinical specimens",
    "Indications for Use Summary": "Qualitative detection of plasmid and chromosomal DNA sequences from B. anthracis in human respiratory samples, blood, serum, plasma, lesion swabs, CSF, pleural fluid, and bacterial culture isolates from suspected anthrax cases; results from direct specimen testing are presumptive, and use is limited to Laboratory Response Network designated laboratories",
    "fda_folder": "Microbiology"
}